Skip to main content
. 2023 Jul 3;26(7):107268. doi: 10.1016/j.isci.2023.107268

Figure 1.

Figure 1

QHRD106 protected against infarction and neurological deficits via B2R after MCAO at different time points

(A) Timeline of the experimental procedure.

(B) Representative brain sections stained with TTC in MCAO model mice 1, 3, and 7 days poststroke.

(C) Infarct volume (n = 10 mice per group).

(D) Rotarod test results (n = 10 mice per group).

(E) Grip strength (n = 10 mice per group).

(F) mNSS scores (n = 10 mice per group).

All data are presented as the mean ± SEM. Statistical analyses were performed by two-way ANOVA followed by Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01 vs. the saline group; #p < 0.05, ##p < 0.01 vs. the QHRD106 group.